SOMA Research

What Is the KLOW Blend? GHK-Cu, BPC-157, TB-500 and KPV

KLOW is a four-component research blend: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg in an 80 mg vial. It is GLOW with KPV added — the name reflects that. Adding a fourth component changes the molar arithmetic more than the mass figure suggests, and it makes the analytical requirements meaningfully harder. This guide covers both.

SOMA Research supplies KLOW for laboratory research use only. It is not a drug, supplement, food or cosmetic, is not approved by the FDA for any use, and is not intended for human or veterinary consumption.

The four components

Component Mass Molecular weight What it is
GHK-Cu 50 mg ~403.9 g/mol Copper tripeptide-1 — a peptide–metal complex
BPC-157 10 mg ~1,419.5 g/mol 15-residue gastric protein fragment
TB-500 10 mg ~889 g/mol Acetylated LKKTETQ, a thymosin β4 fragment
KPV 10 mg ~342.4 g/mol Lys-Pro-Val, an α-MSH(11–13) tripeptide

KPV contributes more molecules than its mass suggests

KPV is 12.5% of the vial by mass — the same as BPC-157 and TB-500. It is also the smallest molecule in the blend at 342.4 g/mol, which means the same 10 mg contains far more of it.

Component Mass By mass Amount By moles
GHK-Cu 50 mg 62.5% ~123.8 µmol 72.3%
KPV 10 mg 12.5% ~29.2 µmol 17.0%
TB-500 10 mg 12.5% ~11.2 µmol 6.6%
BPC-157 10 mg 12.5% ~7.0 µmol 4.1%
Total 80 mg ~171.3 µmol

Three components share an identical 10 mg mass and are present in ratios of roughly 4 : 1.6 : 1 — KPV to TB-500 to BPC-157. Equal masses are nowhere near equal molar amounts, and a blend label expressed in milligrams conceals that entirely.

Figures are calculated from the stated composition and published molecular weights, before correction for salt content; the lot CoA’s peptide-content figures refine them. This is arithmetic, not a claim about what the blend does.

Four components make the chromatography harder

This is where KLOW genuinely differs from a two- or three-component blend, and it is worth a specific look at any certificate.

Reversed-phase HPLC separates by hydrophobicity. The four components do not spread evenly across that axis:

  • GHK-Cu (~403.9) and KPV (~342.4) are both small and polar, and both will elute early, close to the void volume and close to one another.
  • TB-500 (~889) and BPC-157 (~1,419.5) are larger and more retained, and should separate comfortably from the first pair and from each other.

So the resolution risk in KLOW is concentrated in one place: the two small polar components at the front of the run. In GLOW there is only one early-eluting species and no such pairing. A gradient that resolves GLOW adequately will not necessarily resolve KLOW, because it is now being asked to separate two polar molecules from each other in the region where reversed-phase has least retention to work with.

Practically: on a KLOW certificate, look at the early part of the trace and confirm two distinct, baseline-resolved peaks rather than one broad feature. If the method cannot separate GHK-Cu from KPV, no purity figure for either component means much.

Reading a four-component CoA

  • Four resolved components, reported separately. A single purity percentage across four molecules is uninterpretable.
  • Four masses: approximately 342.4, 403.9, 889 and 1,419.5. Note the first two differ by only about 61 Da, so the mass spectrometry needs to resolve them as cleanly as the chromatography does.
  • Ratio separately from purity. Four components can each be pure and still be in the wrong proportions.
  • Which GHK species was measured — free tripeptide (~340.4) or copper complex (~403.9). Note that free GHK at 340.4 is within about 2 Da of KPV at 342.4, so a certificate that reports the wrong species here is also reporting a mass that sits almost on top of another component’s.

Our Certificate of Analysis guide covers the fields; measured figures per lot are in the CoA library.

Handling and storage

The constraints are inherited from the most demanding component, which here is GHK-Cu:

  • Lyophilised powder: -20°C, protected from light — required by the copper complex.
  • Reconstituted stock: 2–8°C, aliquoted, used within approximately 30 days.
  • No chelators — EDTA, EGTA or citrate will strip copper from the GHK-Cu component and silently convert it to free GHK while leaving the other three untouched.
  • No reducing agents, which would alter the copper oxidation state.
  • Colour as a check. The blend should carry the blue to blue-violet of the copper complex; loss of it indicates that component has degraded.
  • None of the four contains methionine, cysteine or tryptophan, so the oxidation failure modes that complicate storage of some other compounds have nothing to act on here — relevant because copper is redox-active.
  • The ratio is fixed on reconstitution and the components cannot be separated on a normal bench. Work needing them independently must source them independently.

Procedure and concentration arithmetic — per component for a blend — are in our reconstitution guide.

Research use only

Research-grade KLOW is supplied for laboratory use by qualified researchers and institutions. It is not manufactured to pharmaceutical standards, has not been approved by the FDA for any use, and must not be used in or on humans or animals. Nothing in this guide is medical advice or a representation that any component is safe or effective for any purpose.